Abstract
Background Microbiome research has focused on populations that are predominantly of European descent, and from narrow demographics that do not capture the socio-economic and lifestyle differences which impact human health. This limits our understanding of human-host microbiota interactions in their broadest sense. Here we examined the airway microbiology of the Orang Asli, the indigenous peoples of Malaysia. In addition to exploring the carriage and antimicrobial resistance of important respiratory pathobionts, we also present the first investigation of the nasal microbiomes of these indigenous peoples, in addition to their oral microbiomes.
Results A total of 130 participants were recruited to the study from Kampung Sungai Pergam and Kampung Berua, both sites in the north-eastern state of Terengganu in Peninsular Malaysia. High levels of Staphylococcus aureus carriage were observed, particularly in the 18-65 age group (n=17/36; 47.2% 95%CI: 30.9-63.5). The highest carriage of pneumococci was in the <5 and 5 to 17 year olds, with 57.1% (4/7) and 49.2% (30/61) respectively. Sixteen pneumococcal serotypes were identified, the most common being the non-vaccine type 23A (14.6%) and the vaccine type 6B (9.8%). The nasal microbiome was significantly more diverse in those aged 5-17 years compared to 50+ years (p = 0.023). In addition, samples clustered by age (PERMANOVA analysis of the Bray-Curtis distance, p = 0.001). Hierarchical clustering of Bray-Curtis dissimilarity scores revealed six microbiome types. The largest cluster (n=28; 35.4%) had a marked abundance of Corynebacterium.
Others comprised Corynebacterium with Dolosigranulum, two clusters were definable by the presence of Moraxella, one with and the other without Haemophilus, a small grouping of Delftia/ Ochrobactum profiles and one with Streptococcus. No Staphylococcus profiles were observed. In the oral microbiomes Streptococcus, Neisseria and Haemophilus were dominant. Lower levels of Prevotella, Rothia, Porphyromonas, Veillonella and Aggregatibacter were also among the eight most observed genera.
Conclusions We present the first study of Orang Asli airway microbiomes and pathobiont microbiology. Key findings include the prevalence of pneumococcal serotypes that would be covered by pneumococcal conjugate vaccines if introduced into a Malaysian national immunisation schedule, and the high level of S. aureus carriage. The dominance of Corynebacterium in the airway microbiomes is particularly intriguing given its’ consideration as a potentially protective commensal with respect to acute infection and respiratory health.
Competing Interest Statement
SCC acts as principal investigator on studies conducted on behalf of University Hospital Southampton NHS Foundation Trust/University of Southampton that are sponsored by vaccine manufacturers but receives no personal payments from them. SCC has participated in advisory boards for vaccine manufacturers but receives no personal payments for this work. SCC has received financial assistance from vaccine manufacturers to attend conferences. DWC was a post-doctoral researcher on projects funded by Pfizer and GSK between April 2014 and October 2017. All grants and honoraria are paid into accounts within the respective NHS Trusts or Universities, or to independent charities. All other authors have no conflicts of interest.
Funding Statement
The laboratory microbiology work was funded by a grant from the Higher Education Funding Council for England (HEFCE) Newton Fund Official Development Assistance (ODA) fund. The microbiome sequencing was funded through a uBiome Inc. Microbiome Grants Initiative award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for this study was provided by Universiti Sultan Zainal Abidin (UniSZA) Ethics Committee: approval no. UniSZA/C/1/UHREC/628-1(85) dated 27th June 2016, the Department of Orang Asli Affairs and Development (JAKOA): approval no. JAKOA/PP.30.052Jld11 (42), and by the University of Southampton Faculty of Medicine Ethics Committee (Submission ID: 20831).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Sequence files and associated metadata have been deposited in the European Nucleotide Archive (ENA) in project PRJEB38610 under experiment accessions ERX4147052 to ERX4147288.